Depression, inflammation, and epidermal growth factor receptor (EGFR) status in metastatic non-small cell lung cancer: A pilot study.

Journal of Psychosomatic Research(2017)

引用 26|浏览8
暂无评分
摘要
•EGFR mutations in stage IV non-small cell lung cancer (NSCLC) protect against depression.•Patients with EGFR mutations exhibit elevated proinflammatory marker TNF-α.•Genotyping may be used as an indicator for patients with NSCLC at risk for depression.
更多
查看译文
关键词
Non-small cell lung cancer,Genotyping,Epidermal growth factor receptor,Depression,Inflammatory cytokines,Oncology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要